30 October 2025
Bold Ideas, Bright Futures: Brilliance in Medical Affairs was the theme of this year’s joint Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Australasia Medical Affairs Summit. The 2-day meeting was held on 24 and 25 September in Sydney, Australia, and welcomed over 300 attendees and 75 faculty members.
A simple scoring system can predict the chances of children with a respiratory tract infection being admitted to hospital, thereby helping to target antibiotics more appropriately. This important finding is highlighted in a commentary written by Chris Winchester, Managing Director of Oxford PharmaGenesis, and colleagues, which is published today in Lancet Respiratory Medicine.
I strongly believe that entering a workplace can be an extremely daunting prospect. Will the other employees be friendly? Am I going to like the work? What if I do something wrong? These are questions that I have asked myself before each work experience. However, in the case of this work experience, these turned out…
With the success of Team GB at this year’s Olympics in Rio, Oxford PharmaGenesis refused to miss out on all the fun. We held our own Office Games in Oxford to raise money for the charity Worldwide Cancer Research (www.worldwidecancerresearch.org), which funds promising cancer research in world-renowned institutions across the globe. The company sponsored each…
Oxford PharmaGenesis was proud to present the results of its research into the benefits of medical writing support for randomized controlled trial (RCT) reporting at the fifth Evidence Live conference, held at the University of Oxford, 22–24 June 2016.
Oxford PharmaGenesis is celebrating a third award for their original research demonstrating that professional medical writing support improves the quality of clinical trial reporting. “We’re delighted that our independent research has again been recognized as an important milestone for our industry”, says co-author and Commercial Director, Dr Richard White.
Oxford PharmaGenesis recently attended the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held in Washington, DC (21–25 May 2016). There was a wide variety of stakeholders in market access and health economics and outcomes research (HEOR) from the pharmaceutical industry, government agencies and academia at the meeting, as…
